AU3255097A - Novel (n)-alkoxyadenine derivatives acting as cytokine inhibitors - Google Patents

Novel (n)-alkoxyadenine derivatives acting as cytokine inhibitors

Info

Publication number
AU3255097A
AU3255097A AU32550/97A AU3255097A AU3255097A AU 3255097 A AU3255097 A AU 3255097A AU 32550/97 A AU32550/97 A AU 32550/97A AU 3255097 A AU3255097 A AU 3255097A AU 3255097 A AU3255097 A AU 3255097A
Authority
AU
Australia
Prior art keywords
alkoxyadenine
novel
cytokine inhibitors
derivatives acting
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU32550/97A
Inventor
Andrew Neil Bowler
Lars Knutsen
Uffe Bang Olsen
Stanley M. Roberts
David R. Varley
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novo Nordisk AS
Original Assignee
Novo Nordisk AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk AS filed Critical Novo Nordisk AS
Publication of AU3255097A publication Critical patent/AU3255097A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/32—Nitrogen atom
    • C07D473/34—Nitrogen atom attached in position 6, e.g. adenine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU32550/97A 1996-07-05 1997-07-03 Novel (n)-alkoxyadenine derivatives acting as cytokine inhibitors Abandoned AU3255097A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DK745/96 1996-07-05
DK74596 1996-07-05
PCT/DK1997/000293 WO1998001459A1 (en) 1996-07-05 1997-07-03 Novel n-alkoxyadenine derivatives acting as cytokine inhibitors

Publications (1)

Publication Number Publication Date
AU3255097A true AU3255097A (en) 1998-02-02

Family

ID=8097056

Family Applications (1)

Application Number Title Priority Date Filing Date
AU32550/97A Abandoned AU3255097A (en) 1996-07-05 1997-07-03 Novel (n)-alkoxyadenine derivatives acting as cytokine inhibitors

Country Status (3)

Country Link
AU (1) AU3255097A (en)
WO (1) WO1998001459A1 (en)
ZA (1) ZA975986B (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU44900A (en) 1998-01-31 2003-01-31 Glaxo Group Limited 2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives
AU2002323990B2 (en) * 1998-06-23 2006-03-30 Glaxo Group Limited Adenosine derivatives
SK19542000A3 (en) * 1998-06-23 2001-09-11 Glaxo Group Limited 2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives, process for producing thereof, pharmaceutical composition them containing, their use and intermediates
GB9813565D0 (en) * 1998-06-23 1998-08-19 Glaxo Group Ltd Chemical compounds
GB9813540D0 (en) * 1998-06-23 1998-08-19 Glaxo Group Ltd Chemical compounds
GB9813535D0 (en) * 1998-06-23 1998-08-19 Glaxo Group Ltd Chemical compounds
GB9813554D0 (en) * 1998-06-23 1998-08-19 Glaxo Group Ltd Chemical compounds
AU778450B2 (en) 1999-07-02 2004-12-09 Eisai R&D Management Co., Ltd. Fused imidazole compounds and remedies for diabetes mellitus
GB0022695D0 (en) 2000-09-15 2000-11-01 Pfizer Ltd Purine Derivatives
GB0106867D0 (en) 2001-03-20 2001-05-09 Glaxo Group Ltd Process
AU2002951247A0 (en) * 2002-09-06 2002-09-19 Alchemia Limited Compounds that interact with kinases
CA2515068A1 (en) * 2003-02-03 2004-08-19 Cv Therapeutics Inc. Partial and full agonists of a1 adenosine receptors
AR049384A1 (en) 2004-05-24 2006-07-26 Glaxo Group Ltd PURINA DERIVATIVES
GB0514809D0 (en) 2005-07-19 2005-08-24 Glaxo Group Ltd Compounds
CN104363757B (en) * 2012-02-11 2017-05-24 中央研究院 Methods and compositions for treating pain
CN108676048B (en) * 2018-06-04 2021-04-27 上海兆维科技发展有限公司 Preparation method of cordycepin

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4962194A (en) * 1987-04-02 1990-10-09 Warner-Lambert Company Method of preparing 51,N6-disubstituted adenosines from inosines
IL108523A0 (en) * 1993-02-03 1994-05-30 Gensia Inc Pharmaceutical compositions containing adenosine kinase inhibitors for preventing or treating conditions involving inflammatory responses and pain

Also Published As

Publication number Publication date
ZA975986B (en) 1998-03-23
WO1998001459A1 (en) 1998-01-15

Similar Documents

Publication Publication Date Title
AU4791797A (en) 6-phenylpyridyl-2-amine derivatives useful as nos inhibitors
AU1301697A (en) Tyrosin-derivate as alpha-v-integrin inhibitors
AU4383397A (en) Hetaroyl derivatives
AU3343097A (en) Phenylalamine derivatives as integrin inhibitors
AU4554297A (en) Hetaroyl derivatives
AU5135998A (en) Novel urea derivatives
AUPO395396A0 (en) Benzamide derivatives
AU1735497A (en) Sulfonylureidopyrazole derivatives
AU1594697A (en) New substituted 19-nor-pregnane derivatives
AU7738098A (en) Novel tetrahydrobenzindolone derivatives
AU3867997A (en) Chromene-3-carboxylate derivatives
AU3255097A (en) Novel (n)-alkoxyadenine derivatives acting as cytokine inhibitors
AU2956097A (en) Alkylaminobenzothiazole and -benzoxazole derivatives
AU5652698A (en) (2,3-dihydrobenzofuranyl)-thiazoles as phosphodiesterase inhibitors
EP1008579A3 (en) Cyclopentenebutanol derivatives
AU1605699A (en) Substituted 3-amino-2-hydroxyphenylacetamide derivatives as enzyme inhibitors (ii)
AU3827897A (en) 3-mercaptoacetylamino-1,5-substituted-2-oxo-azepan derivatives useful as inhibitors of matrix metalloproteinase
AU2961097A (en) Substituted pyrazolylpyrazole derivatives
AU4962097A (en) 2-methoxyphenylpiperazine derivatives
AU4622597A (en) Novel pyranoside derivatives
AU1793197A (en) Pyrazole-4-yl-hetaroyl derivatives
AUPO863197A0 (en) Novel derivatives
AU6994396A (en) Substituted indolylpropyl-piperazine derivatives as 5-ht1dalpha agonists
AU3685097A (en) N-benzylazolium derivatives
AU3906997A (en) Novel heterocycle compositions